Reply to improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levelsBENSON, M. C.The Prostate. 1998, Vol 37, Num 3, pp 138-139, issn 0270-4137Article

The role of tumor biomarkers as predictors of serum PSA recurrence after radical prostatectomyDE LA TAILLE, A; BUTTYAN, R; BENSON, M. C et al.Seminars in urologic oncology. 1998, Vol 16, Num 3, pp 137-144, issn 1081-0943Article

Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancerINGENITO, A. C; ENNIS, R. D; HSU, I.-C et al.Urology (Ridgewood, NJ). 1997, Vol 50, Num 1, pp 73-78, issn 0090-4295Article

Molecular staging of genitourinary malignanciesKATZ, A. E; DE VRIES, G. M; OLSSON, C. A et al.Urology (Ridgewood, NJ). 1996, Vol 47, Num 6, pp 948-958, issn 0090-4295Article

Giant multilocular cystadenoma of the prostateKIRSCH, A. J; NEWHOUSE, J; HIBSHOOSH, H et al.Urology (Ridgewood, NJ). 1996, Vol 48, Num 2, pp 303-305, issn 0090-4295Article

The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomyKATZ, A. E; DE VRIES, G. M; BENSON, M. C et al.Urologic clinics of North America. 1996, Vol 23, Num 4, pp vii-viii, issn 0094-0143, 11 p.Article

External beam radiation therapy does not offer long-term control of prostate cancerGOLUBOFF, E. T; BENSON, M. C.Urologic clinics of North America. 1996, Vol 23, Num 4, issn 0094-0143, ix, 617-621 [6 p.]Article

Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostateSEAMAN, E. K; WHANG, I. S; COONER, W et al.Urology (Ridgewood, NJ). 1994, Vol 43, Num 5, pp 645-648, issn 0090-4295Article

Toward objective prognostic grading of prostatic carcinoma using image analysisIRINOPOULOU, T; RIGAUT, J. P; BENSON, M. C et al.Analytical and quantitative cytology and histology. 1993, Vol 15, Num 5, pp 341-344, issn 0884-6812Conference Paper

Flow cytometric determination of the multidrug resistant phenotype in transitional cell cancer of the bladder : implications and applications. Editorial commentsBENSON, M. C; GIELLA, J; IHN SEONG WHANG et al.The Journal of urology. 1991, Vol 146, Num 4, pp 982-987, issn 0022-5347Article

The application of flow cytometry to the assessment of tumor cell heterogeneity and the grading of human prostatic cancer: preliminary resultsBENSON, M. C; WALSH, P. C.The Journal of urology. 1986, Vol 135, Num 6, pp 1194-1198, issn 0022-5347Article

Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen : Long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomyDE LA TAILLE, A; OLSSON, C. A; BUTTYAN, R et al.International journal of cancer. 1999, Vol 84, Num 4, pp 360-364, issn 0020-7136Article

Prostate-specific antigen and other serum markers : Current concepts from the world health organization second international consultation on prostate cancerBRAWER, M. K; BENSON, M. C; BOSTWICK, D. G et al.Seminars in urologic oncology. 1999, Vol 17, Num 4, pp 206-221, issn 1081-0943Article

Comment on: The ileal ureter neobladder is associated with a high success and a low complication rate. Authors' replyBENSON, M. C; SEAMAN, E. K; OLSSON, C. A et al.The Journal of urology. 1997, Vol 157, Num 6, issn 0022-5347, p. 2266Article

Pretreatment prostate specific antigen doubling times : Use in patients before radical prostatectomy. CommentaryGOLUBOFF, E. T; HEITJAN, D. F; DEVRIES, G. M et al.The Journal of urology. 1997, Vol 158, Num 5, pp 1876-1879, issn 0022-5347Article

PSA density (PSAD) : role in patient evaluation and managementSEAMAN, E; WHANG, M; OLSSON, C. A et al.Urologic clinics of North America. 1993, Vol 20, Num 4, pp 653-663, issn 0094-0143Article

Prostate-specific antigen density : a new prognostic indicator for prostate cancerZENTNER, P. G; PAO, L. K; BENSON, M. C et al.International journal of radiation oncology, biology, physics. 1993, Vol 27, Num 1, pp 47-58, issn 0360-3016Conference Paper

Prostate specific antigen density : a means of distinguishing benign prostatic hypertrophy and prostate cancerBENSON, M. C; IHN SEONG WHANG; PANTUCK, A et al.The Journal of urology. 1992, Vol 147, Num 3, pp 815-816, issn 0022-5347, 2Article

Detection of cellular proliferation during compensatory renal growth using flow cytometryRING, K. S; BENSON, M. C; BANDYK, M. G et al.Nephron. 1992, Vol 61, Num 2, pp 200-203, issn 0028-2766Article

Analysis of continent versus standard urinary diversionBENSON, M. C; SLAWIN, K. M; WECHSLER, M. H et al.British journal of urology (Print). 1992, Vol 69, Num 2, pp 156-162, issn 0007-1331Conference Paper

A report of cytomegalovirus cystitis and a review of other genitourinary manifestations of the acquired immune deficiency syndromeBENSON, M. C; KAPLAN, M. S; O'TOOLE, K et al.The Journal of urology. 1988, Vol 140, Num 1, pp 153-154, issn 0022-5347Article

Predictive Significance of Surgical Margin Status After Prostatectomy for Prostate Cancer During PSA EraMANN, M. J; DECASTRO, G. J; DESAI, M et al.Urology (Ridgewood, NJ). 2008, Vol 72, Num 6, pp 1203-1207, issn 0090-4295, 5 p.Article

Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cellsYANG, X; CHEN, M.-W; BUTTYAN, R et al.Oncogene (Basingstoke). 2006, Vol 25, Num 24, pp 3436-3444, issn 0950-9232, 9 p.Article

Salvage cryotherapy for recurrent prostate cancer after radiation therapy : The columbia experienceDE LA TAILLE, A; HAYEK, O; BENSON, M. C et al.Urology (Ridgewood, NJ). 2000, Vol 55, Num 1, pp 79-84, issn 0090-4295Article

Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille calmette-guerinSAROSDY, M. F; MANYAK, M. J; SAGALOWSKY, A. I et al.Urology (Ridgewood, NJ). 1998, Vol 51, Num 2, pp 226-231, issn 0090-4295Article